U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LEMALESOMAB
INN   WHO-DD  
INN  
Official Name English
lemalesomab [INN]
Preferred Name English
Lemalesomab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN NCA-90 GRANULOCYTE CELL ANTIGEN) (MOUSE MONOCLONAL IMMU-MN3 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL IMMU-MN3 .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
ChEMBL
CHEMBL2109127
Created by admin on Mon Mar 31 23:19:19 GMT 2025 , Edited by admin on Mon Mar 31 23:19:19 GMT 2025
PRIMARY
NCI_THESAURUS
C175107
Created by admin on Mon Mar 31 23:19:19 GMT 2025 , Edited by admin on Mon Mar 31 23:19:19 GMT 2025
PRIMARY
SMS_ID
300000021914
Created by admin on Mon Mar 31 23:19:19 GMT 2025 , Edited by admin on Mon Mar 31 23:19:19 GMT 2025
PRIMARY
FDA UNII
018649S21N
Created by admin on Mon Mar 31 23:19:19 GMT 2025 , Edited by admin on Mon Mar 31 23:19:19 GMT 2025
PRIMARY
CAS
250242-54-7
Created by admin on Mon Mar 31 23:19:19 GMT 2025 , Edited by admin on Mon Mar 31 23:19:19 GMT 2025
PRIMARY
INN
8046
Created by admin on Mon Mar 31 23:19:19 GMT 2025 , Edited by admin on Mon Mar 31 23:19:19 GMT 2025
PRIMARY
ACTIVE MOIETY
LEMALESOMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966